NEW YORK, Sept. 5 - First Genetic Trust today said the International Genomics Consortium will use its databanking systems in its plan to sequence tumors.
Terms of the agreement call for First Genetic Trust to provide the IGC with its web-based enTrust system, which First Genetic said will enable researchers there to enroll 10,000 patients from as many as 20 academic cancer centers in the United States.
The IGC, meantime, said its Expression Project in Oncology, or expO, will build a freely available database of gene expression in human cancer.
According to the IGC, expO was devised to collect tumor samples from cancer patients, analyze genomics patterns, and cross-reference them with pathology diagnoses.
Click here for more information.